“Spicing Up” of the Immune System by Curcumin

Curcumin (diferuloylmethane) is an orange-yellow component of turmeric (Curcuma longa), a spice often found in curry powder. Traditionally known for its an antiinflammatory effects, curcumin has been shown in the last two decades to be a potent immunomodulatory agent that can modulate the activation of T cells, B cells, macrophages, neutrophils, natural killer cells, and dendritic cells. Curcumin can also downregulate the expression of various proinflammatory cytokines including TNF, IL-1, IL-2, IL-6, IL-8, IL-12, and chemokines, most likely through inactivation of the transcription factor NF-κB. Interestingly, however, curcumin at low doses can also enhance antibody responses. This suggests that curcumin’s reported beneficial effects in arthritis, allergy, asthma, atherosclerosis, heart disease, Alzheimer’s disease, diabetes, and cancer might be due in part to its ability to modulate the immune system. Together, these findings warrant further consideration of curcumin as a therapy for immune disorders.

[1]  J. Gertsch,et al.  Curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells. , 2003, Bioorganic & medicinal chemistry.

[2]  K. M. Nadkarni The Indian Materia Medica , 1927, The Indian Medical Gazette.

[3]  A. Lumsden,et al.  Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. , 2005, Journal of the American College of Surgeons.

[4]  M. Sugano,et al.  Effect of natural food colorings on immunoglobulin production in vitro by rat spleen lymphocytes. , 1996, Bioscience, biotechnology, and biochemistry.

[5]  B. Timmermann,et al.  The effect of turmeric extracts on inflammatory mediator production. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[6]  K. Srinivasan,et al.  Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat , 1995, Molecular and Cellular Biochemistry.

[7]  B. Aggarwal,et al.  Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.

[8]  M. Sugano,et al.  Effects of dietary fats and curcumin on IgE-mediated degranulation of intestinal mast cells in brown Norway rats. , 1996, Bioscience, biotechnology, and biochemistry.

[9]  V. Kapoor,et al.  Anti-inflammatory studies on Curcuma longa (turmeric). , 1971, The Indian journal of medical research.

[10]  D. Flynn,et al.  Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. , 1986, Prostaglandins, leukotrienes, and medicine.

[11]  S. Seth,et al.  Medicinal plants in India. , 2004, The Indian journal of medical research.

[12]  J. Remacle,et al.  Is the Effect of Interleukin-1 on Glutathione Oxidation in Cultured Human Fibroblasts Involved in Nuclear Factor-κB Activation? , 2001 .

[13]  R. Puvanakrishnan,et al.  Protective role of curcumin against isoproterenol induced myocardial infarction in rats , 1996, Molecular and Cellular Biochemistry.

[14]  L. Howells,et al.  Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.

[15]  M. Bertagnolli,et al.  Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. , 2000, The Journal of surgical research.

[16]  Ashutosh Kumar Singh,et al.  Enhancement of wound healing by curcumin in animals , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[17]  H. Cheng,et al.  [Protective effect of curcumin on myocardial ischemia reperfusion injury in rats]. , 2005, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[18]  V. Singh,et al.  Immunomodulatory Effects of Curcumin , 2005, Immunopharmacology and immunotoxicology.

[19]  M. Azuine,et al.  Chemoprevention of mammary tumor virus-induced and chemical carcinogen-induced rodent mammary tumors by natural plant products , 2004, Breast Cancer Research and Treatment.

[20]  M. Chan,et al.  In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. , 1998, Biochemical pharmacology.

[21]  B. Aggarwal,et al.  Curcumin‐induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IκB kinase and nuclear factor κB activity and are independent of the B‐Raf/mitogen‐activated/extracellular signal‐regulated protein kinase pathway and the Akt pathway , 2005, Cancer.

[22]  G. Bernardi,et al.  Curcumin Inhibits Activation of Vγ9Vδ2 T Cells by Phosphoantigens and Induces Apoptosis Involving Apoptosis-Inducing Factor and Large Scale DNA Fragmentation1 , 2001, The Journal of Immunology.

[23]  B. Joe,et al.  Dietary n-3 fatty acids, curcumin and capsaicin lower the release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages , 2004, Molecular and Cellular Biochemistry.

[24]  L. Xinjian,et al.  Effect of curcumin on immune function of mice , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[25]  Yung-Hyun Choi,et al.  Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. , 2006, Oncology reports.

[26]  V. Kalra,et al.  Curcumin, the active constituent of turmeric, inhibits amyloid peptide‐induced cytochemokine gene expression and CCR5‐mediated chemotaxis of THP‐1 monocytes by modulating early growth response‐1 transcription factor , 2004, Journal of neurochemistry.

[27]  K. Singletary,et al.  Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. , 1996, Cancer letters.

[28]  J. Holy Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. , 2002, Mutation research.

[29]  A. Gomez-Muñoz,et al.  Curcumin attenuates DNB-induced murine colitis. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[30]  B. Evers,et al.  Curcumin Inhibits Neurotensin-Mediated Interleukin-8 Production and Migration of HCT116 Human Colon Cancer Cells , 2006, Clinical Cancer Research.

[31]  B. Aggarwal,et al.  Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. , 2005, Biochemical pharmacology.

[32]  B. Ghosh,et al.  Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. , 1999, International journal of immunopharmacology.

[33]  Z. Yuan,et al.  Curcumin ameliorates left ventricular function in rabbits with pressure overload: inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha and matrix metalloproteinase-2 expression. , 2004, Biological & pharmaceutical bulletin.

[34]  H. Ohshima,et al.  Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. , 1995, Biochemical and biophysical research communications.

[35]  Udaykumar Ranga,et al.  Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription* , 2004, Journal of Biological Chemistry.

[36]  L. Chaudhary,et al.  Regulation of Interleukin-8 Gene Expression by Interleukin-1β, Osteotropic Hormones, and Protein Kinase Inhibitors in Normal Human Bone Marrow Stromal Cells* , 1996, The Journal of Biological Chemistry.

[37]  C. Crumpacker,et al.  Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. O’Neill,et al.  Inhibition of nuclear factor kappaB by direct modification in whole cells--mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. , 1998, Biochemical pharmacology.

[39]  Changguo Chen,et al.  Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. , 2003, The Journal of surgical research.

[40]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[41]  H. Uzun,et al.  Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis. , 2006, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.

[42]  N. Vanittanakom,et al.  Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). , 1995, Journal of ethnopharmacology.

[43]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[44]  Tirunelveli S. Ramalingam,et al.  Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma , 2004, Clinical Cancer Research.

[45]  W. Glasgow,et al.  Curcumin Suppresses Interleukin 1β-Mediated Microsomal Prostaglandin E Synthase 1 by Altering Early Growth Response Gene 1 and Other Signaling Pathways , 2005, Journal of Pharmacology and Experimental Therapeutics.

[46]  W. R. Bishop,et al.  Farnesyl Transferase Inhibitors: Mechanism of Action, Translational Studies and Clinical Evaluation , 2003, Cancer biology & therapy.

[47]  B. Lokesh,et al.  Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats. , 1996, Toxicology.

[48]  Hao Jiang,et al.  Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. , 2003, Molecular cancer therapeutics.

[49]  P. Méndez-Samperio,et al.  Roles of intracellular calcium and NF-kappaB in the Bacillus Calmette-Guérin-induced secretion of interleukin-8 from human monocytes. , 2001, Cellular immunology.

[50]  K. Miyake,et al.  Inhibition of homodimerization of Toll-like receptor 4 by curcumin. , 2006, Biochemical pharmacology.

[51]  B. Aggarwal,et al.  Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.

[52]  G. Kuttan,et al.  Immunomodulatory activity of curcumin. , 1999, Immunological investigations.

[53]  S. Dulchavsky,et al.  Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. , 2004, Molecular cancer therapeutics.

[54]  Z. Gil,et al.  Curcumin: A new radio-sensitizer of squamous cell carcinoma cells , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[55]  A. Khar,et al.  Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells , 2000, FEBS letters.

[56]  Chang-sheng Deng,et al.  Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. , 2006, World journal of gastroenterology.

[57]  S. Jee,et al.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.

[58]  R. Srimal,et al.  Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent * , 1973, The Journal of pharmacy and pharmacology.

[59]  M. K. Heng,et al.  Drug‐induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters , 2000, The British journal of dermatology.

[60]  R. Srivastava Inhibition of neutrophil response by curcumin , 1989, Agents and Actions.

[61]  E. Bahraoui,et al.  Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. , 1998, Research in virology.

[62]  C. Ho,et al.  Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. , 1995, Cancer letters.

[63]  M. Rezvani,et al.  Modification of radiation‐induced acute oral mucositis in the rat , 2004, International journal of radiation biology.

[64]  Y. Surh,et al.  Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. , 2005, Antioxidants & redox signaling.

[65]  A. Takeshita,et al.  CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts , 1996, Infection and immunity.

[66]  M. Guenounou,et al.  Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. , 2002, Cytokine.

[67]  M. Ladanyi,et al.  EWS-CREB1: A Recurrent Variant Fusion in Clear Cell Sarcoma—Association with Gastrointestinal Location and Absence of Melanocytic Differentiation , 2006, Clinical Cancer Research.

[68]  P. But,et al.  Pharmacology and applications of chinese materia medica , 1986 .

[69]  Jing-Gung Chung,et al.  Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B /p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. , 2006, Anticancer research.

[70]  Yuetsu Tanaka,et al.  Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. , 2006, Leukemia research.

[71]  B. Joe,et al.  Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. , 1994, Biochimica et biophysica acta.

[72]  K. Srinivasan,et al.  Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats , 2004, Molecular and Cellular Biochemistry.

[73]  P. Negi,et al.  Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. , 1999, Journal of agricultural and food chemistry.

[74]  Yuetsu Tanaka,et al.  Retracted: Curcumin (diferuloylmethane) inhibits constitutive active NF‐κB, leading to suppression of cell growth of human T‐cell leukemia virus type I‐infected T‐cell lines and primary adult T‐cell leukemia cells , 2006 .

[75]  R. Smart,et al.  Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. , 1988, Cancer research.

[76]  V. Lampe,et al.  Studien über Curcumin , 1913 .

[77]  S. Han,et al.  Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. , 1999, Clinical immunology.

[78]  Soon-Cheol Ahn,et al.  Curcumin Inhibits Immunostimulatory Function of Dendritic Cells: MAPKs and Translocation of NF-κB as Potential Targets1 , 2005, The Journal of Immunology.

[79]  D. Shoskes Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. , 1998, Transplantation.

[80]  M. Chan Inhibition of tumor necrosis factor by curcumin, a phytochemical. , 1995, Biochemical pharmacology.

[81]  C. Boland,et al.  Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. , 2001, Cancer letters.

[82]  G. Kuttan,et al.  Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.

[83]  J. Funk,et al.  Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. , 2006, Journal of natural products.

[84]  S. Hoffman,et al.  Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. , 2004, American journal of respiratory cell and molecular biology.

[85]  D. Shoskes,et al.  Quercetin and curcumin up-regulate antioxidant gene expression in rat kidney after ureteral obstruction or ischemia/reperfusion injury. , 2001, Transplantation proceedings.

[86]  Y. Song,et al.  Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. , 2003, Carcinogenesis.

[87]  P. Ortiz de Montellano,et al.  Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. , 1993, Bioorganic & medicinal chemistry.

[88]  D. Sohn,et al.  A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria. , 2001, Planta medica.

[89]  Joon-Oh Park,et al.  Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. , 2005, Biochemical and biophysical research communications.

[90]  G. Cole,et al.  The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.

[91]  B. Aggarwal,et al.  Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1 , 2003 .

[92]  L. Sarma,et al.  Protective effects of chlorogenic acid, curcumin and beta-carotene against gamma-radiation-induced in vivo chromosomal damage. , 1993, Mutation research.

[93]  D. Sohn,et al.  A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-α release from Curcuma zedoaria , 2001 .

[94]  S. Gautam,et al.  Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. , 1997, Hematopathology and molecular hematology.

[95]  Y. Murakami,et al.  Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, alpha-diisoeugenol. , 2005, Anticancer research.

[96]  M. Festing,et al.  Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[97]  N. Nalini,et al.  Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats , 2002, Plant foods for human nutrition.

[98]  M. Nair,et al.  Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[99]  L. Elliott,et al.  Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. , 1998, The Journal of surgical research.

[100]  Y. Surh,et al.  Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. , 2002, Journal of biochemistry and molecular biology.

[101]  H. Kishida,et al.  Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. , 2005, Biological & pharmaceutical bulletin.

[102]  A. Garg,et al.  Chemosensitization and radiosensitization of tumors by plant polyphenols. , 2005, Antioxidants & redox signaling.

[103]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[104]  M. Dikshit,et al.  Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart. , 1995, The Indian journal of medical research.

[105]  Bao Q. Pham,et al.  Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B* , 2000, The Journal of Biological Chemistry.

[106]  Jeen-Woo Park,et al.  Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. , 2006, Carcinogenesis.

[107]  T. Horie,et al.  Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. , 1997, Biochemical pharmacology.

[108]  V. Mohan,et al.  Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications , 2003, Journal of Biosciences.

[109]  Mansoor M Ahmed,et al.  Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3 , 2004, Oncogene.

[110]  J. Exon,et al.  Dietary curcumin enhances antibody response in rats. , 1997, Immunopharmacology and immunotoxicology.

[111]  V. Steele,et al.  Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. , 1996, Carcinogenesis.

[112]  Yan-TingJian,et al.  Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid , 2005 .

[113]  J. Hoidal,et al.  Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. , 1998, American journal of physiology. Heart and circulatory physiology.

[114]  S. Hwang,et al.  Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. , 1999, European journal of pharmacology.

[115]  S. Katz,et al.  Curcumin Therapy in Inflammatory Bowel Disease: A Pilot Study , 2005, Digestive Diseases and Sciences.

[116]  Ashutosh Kumar Singh,et al.  Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[117]  A. Olson,et al.  Active site binding modes of curcumin in HIV-1 protease and integrase. , 2005, Bioorganic & medicinal chemistry letters.

[118]  N. Ghatak,et al.  Anti-inflammatory and irritant activities of curcumin analogues in rats , 1982, Agents and Actions.

[119]  Y. Yuzawa,et al.  Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. , 2004, Journal of the American Society of Nephrology : JASN.

[120]  H. Ammon,et al.  Pharmacology of Curcuma longa , 1991, Planta medica.

[121]  J. Bright,et al.  Curcumin Inhibits Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through Janus Kinase-STAT Pathway in T Lymphocytes1 , 2002, The Journal of Immunology.

[122]  C. Rao,et al.  Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. , 1995, Cancer research.

[123]  T. Horie,et al.  Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. , 1999, Pharmacological research.

[124]  V. Menon,et al.  Protection of pancreatic beta-cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[125]  Fei Wang,et al.  The Sensitive Fluorimetric Method for the Determination of Curcumin Using the Enhancement of Mixed Micelle , 2006, Journal of Fluorescence.

[126]  S. K. Abraham,et al.  Protective effects of chlorogenic acid, curcumin and β-carotene against γ-radiation-induced in vivo chromosomal damage , 1993 .

[127]  B. Aggarwal,et al.  Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. , 2003, Carcinogenesis.

[128]  L. Stanberry,et al.  Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. , 1999, Antiviral research.

[129]  P. Seth,et al.  Differential Regulation of Cytokines and Transcription Factors in Liver by Curcumin Following Hemorrhage/Resuscitation , 2003, Shock.

[130]  Yung-Hyun Choi,et al.  Curcumin decreases binding of shiga-like toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-α and IL-1β : Suppression of p38, JNK and NF-κB p65 as potential targets , 2006 .

[131]  A. Conney,et al.  Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. , 1991, Cancer research.

[132]  Jong-Wook Park,et al.  Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). , 2005, Carcinogenesis.

[133]  T. Ogawa,et al.  Gene Expressions of Toll-Like Receptor 2, But Not Toll-Like Receptor 4, Is Induced by LPS and Inflammatory Cytokines in Mouse Macrophages1 , 2000, The Journal of Immunology.

[134]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[135]  Y. Ko,et al.  Effects of nuclear factor‐κB inhibitors and its implication on natural killer T‐cell lymphoma cells , 2005, British journal of haematology.

[136]  K. Piwocka,et al.  Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. , 1997, Biochemical pharmacology.

[137]  K. Piwocka,et al.  Effect of Curcumin on the Apoptosis of Rodent and Human Nonproliferating and Proliferating Lymphoid Cells , 2000, Nutrition and cancer.

[138]  Daniel Normolle,et al.  Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.

[139]  M. Kitamura,et al.  Unexpected Transcriptional Induction of Monocyte Chemoattractant Protein 1 by Proteasome Inhibition: Involvement of the c-Jun N-Terminal Kinase-Activator Protein 1 Pathway1 , 2001, The Journal of Immunology.

[140]  Joon-Oh Park,et al.  Curcumin inhibits interferon-α induced NF-κB and COX-2 in human A549 non-small cell lung cancer cells , 2005 .

[141]  A. Conney,et al.  Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. , 1992, Carcinogenesis.

[142]  Y. Lou,et al.  Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. , 1994, Cancer research.

[143]  S. Dulchavsky,et al.  Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. , 2004, Biochemical pharmacology.

[144]  D. Brenner,et al.  Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.

[145]  Mao-tsun Lin,et al.  Blocking NF-kappaB activation may be an effective strategy in the fever therapy. , 2003, The Japanese journal of physiology.

[146]  J. Weinstein,et al.  Inhibition of human immunodeficiency virus type-1 integrase by curcumin. , 1995, Biochemical pharmacology.

[147]  W. Hunter,et al.  The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis , 2006, Inflammation Research.

[148]  Yuetsu Tanaka,et al.  Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. , 2006, International journal of cancer.

[149]  R. Steinman,et al.  Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins , 1990, The Journal of experimental medicine.

[150]  A. Gescher,et al.  Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials. , 2006, European journal of cancer.

[151]  Babu P. Patlolla,et al.  Effect of Turmeric, Turmerin and Curcumin on Ca2+, Na/K+ Atpases in Concanavalin A-Stimulated Human Blood Mononuclear Cells , 2003 .

[152]  S. Hwang,et al.  Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin‐12 production in macrophages , 1999, British journal of pharmacology.

[153]  B. Bosman Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. , 1994, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[154]  B. Jang,et al.  Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets , 2005, Experimental & Molecular Medicine.

[155]  S. Sang,et al.  Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase , 2004 .

[156]  M. Ogawa,et al.  Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface , 2002, Cancer.

[157]  Jide Wang,et al.  Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. , 2005, World journal of gastroenterology.

[158]  B. Aggarwal,et al.  Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. , 2006, Toxicology.

[159]  Ricky A. Sharma,et al.  Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[160]  G. Wu,et al.  The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. , 1998, The American surgeon.

[161]  S. Pal,et al.  Curcumin induces apoptosis in human breast cancer cells through p53‐dependent Bax induction , 2002, FEBS letters.

[162]  S. Gautam,et al.  Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. , 1997, Experimental hematology.

[163]  Jen-kun Lin,et al.  Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. , 1996, Nutrition and cancer.

[164]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[165]  Ping Wang,et al.  The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-γ* , 2006 .

[166]  J. Sayre,et al.  Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. , 2006, Journal of Alzheimer's disease : JAD.

[167]  B. Ghosh,et al.  Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. , 2003, Biological & pharmaceutical bulletin.

[168]  S. Dulchavsky,et al.  Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-KB through suppression of IKBA phosphorylation , 2004 .

[169]  Jen-kun Lin,et al.  Stability of curcumin in buffer solutions and characterization of its degradation products. , 1997, Journal of pharmaceutical and biomedical analysis.

[170]  J. Miłobȩdzka,et al.  Zur Kenntnis des Curcumins , 1897 .

[171]  K. Mohri,et al.  Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. , 2005, Biological & pharmaceutical bulletin.

[172]  P. Murugan,et al.  Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. , 2006, Life sciences.